Business Wire

Mentice, Together with the ASSERT Centre at University College Cork, Ireland, to Introduce State-of-the-Art Training Solution for Acute Ischemic Stroke (AIS)

Jaa

The ASSERT Centre at University College Cork in Ireland is to host a new mechanical thrombectomy training course featuring Mentice’s high-fidelity endovascular training solution. The training solution is the result of a project part-financed by Vinnova, Sweden’s national innovation agency.

ASSERT (Application of Science to Simulation-based Education and Research on Training) plans to hold the two-day course June 29-30. The course combines high-fidelity simulators from Mentice with a ‘proficiency-based progression’ training method.

“This method,” says Mentice CEO Göran Malmberg, “brings system generated objective assessment into the training process. Trainees must demonstrate proficiency in a series of carefully selected training milestones before progressing. These milestones are assessed by the system which makes them entirely objective. It’s a critical development, the number of endovascular interventions for stroke is set to rise dramatically worldwide. Proficiency-based progression with simulation based structured training will not only help to radically reduce the cost of skills development but also help scale this procedure in a safe way.”

Mechanical thrombectomy—a revolutionary new minimally invasive procedure in which a clinical device is introduced into the affected brain’s vasculature to mechanically remove a blood clot—is now recognized as the preferred treatment for acute ischemic stroke. “The shift to interventional treatment of stroke is a fantastic health opportunity that will have the ability to save hundreds of thousands of patients annually worldwide,” comments Malmberg. “This promising procedure will face a multitude of challenges including early diagnosis of stroke and of course effective dispatch of patients to treatment. In addition, effective training of new and existing teams and operators is certainly one big challenge of a safe roll-out, which is where Mentice, ASSERT and proficiency-based progression can really contribute.”

The Mentice training solution deployed by ASSERT has been developed in collaboration with recognized neurovascular specialists Professor Thomas Liebig, Dr. Markus Holtmannspötter and Dr. Robert Crossley, as well as with technology-enhanced learning expert Professor Tony Gallagher of ASSERT.

“Mechanical Thrombectomy for acute stroke,” says Professor Tony Gallagher of ASSERT, “is a life-changing treatment for many gravely ill patients. The success of the treatment is determined in no small part by the skills of the clinician performing the procedure.”

A larger panel with more than 20 experts from 7 countries have been highly involved in validating this new training method which will be shown for the first time during this two-day course, June 29-30.

“We are privileged to have the course facilitated by leading neurovascular specialists at the ASSERT Centre and are confident that this program will be the first of many,” says ASSERT Director/Clinical Lead Professor Barry O’Reilly.

About Mentice

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment opportunities. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a safe environment within the fields of endovascular intervention and minimally invasive surgery. The advantages of training with Mentice solutions are well documented enhancing clinical performance, reducing cost, and, in the long term, improving patient safety. For more information please visit www.mentice.com

About ASSERT

The ASSERT Centre, College of Medicine and Health, University College Cork Ireland is a new state of the art facility dedicated to cadaveric and simulation based healthcare training and research. ASSERT provides both the facility and services ideally suited to conducting all types of training for healthcare practitioners, specialists or teams. ASSERT is ideally placed as the bridge that links clinicians, industry and healthcare research institutes both locally and internationally. For more information, please see www.ucc.ie/assert

Contact information

Mentice AB
Hiral Chavda, Marketing Communications Manager
+46 (0) 31 339 94 94
hiral.chavda@mentice.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

IDEMIA, in Partnership with BGFIBank, Launches for First Time in Gabon a Bank Card Integrating MOTION CODETM20.10.2017 11:16Tiedote

IDEMIA, the global leader in trusted identities for an increasingly digital world, was selected by BGFIBank, the top bank in Central Africa, to launch the new Visa bank card in Gabon integrating MOTION CODE TM , a technology developed by IDEMIA ensuring optimal security especially in Internet transactions and considerably reducing the risk of online fraud. As a reference player in the African banking landscape, the BGFIBank Group has always been a pioneer in the adoption of new technologies in order to offer its customers the most innovative and secure solutions on the market. It is therefore quite natural that BGFIBank chose the expertise of IDEMIA (formerly known as OT-Morpho) to offer its customers high-tech payment cards for the first time in Africa. The adoption of this innovative solution is intended to secure online purchases made by its custo

The Meet Group Announces Closing of Lovoo Acquisition19.10.2017 23:58Tiedote

The Meet Group, Inc. (NASDAQ: MEET), a public market leader in the mobile meeting space, has completed its acquisition of Lovoo GmbH. The LOVOO app is the most downloaded dating app in Germany, Switzerland, and Austria combined. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006572/en/ The Meet Group anticipates this purchase will continue the momentum of its mission to meet the universal need for human connection through innovating, acquiring, and building the largest mobile portfolio of brands for meeting new people. The acquisition is expected to expand The Meet Group’s global footprint, increase the company’s scale and profitability, and diversify its business model by adding expertise in subscription and in-app purchasing. “LOVOO is our third strategic acquisition in the last 12 months, and

Edgewater Networks Announces SD-WAN Optimized for BroadSoft Platforms19.10.2017 23:00Tiedote

Edgewater Networks, Inc., the market leader in Network Edge Orchestration, announces the upcoming availability of its SD-WAN offering targeted for Small to Medium Enterprises, a key market for service providers offering Unified Communications as a Service. Edgewater Networks’ SD-WAN solution is optimized for the BroadSoft BroadWorks® and BroadCloud® platforms and brings the benefits of this technology to the BroadSoft customer base. “As a new component of our Network Edge Orchestration platform, Edgewater Networks SD-WAN service allows BroadSoft customers to offer comprehensive end user service level agreements by ensuring that real-time communications are automatically routed to the best available Internet connection,” said Chris Kolstad, Edgewater Networks’ Vice President of Product Management. “Edgewater Networks’ SD-WAN offers a new revenue stream to service providers with a soluti

Business Wire Receives Type 2 SOC 2 Attestation Engagement Report Related to Security19.10.2017 22:20Tiedote

Business Wire today announced that it has successfully completed a Type 2 SOC 2 examination of its BW Connect and HQ systems. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006400/en/ The attestation engagement report, conducted by the independent CPA firm Schellman & Company, LLC, confirms that Business Wire has met the standards established by the American Institute of Certified Public Accountants [AICPA] Trust Services Principles related to security. BW Connect is Business Wire’s proprietary web-based order-entry system; HQ provides web-hosting services for online newsrooms, and investor relations hubs for publicly-traded companies. The examination, conducted during the review period February 1, 2017 through July 31, 2017, focused on Business Wire adherence to the Trust Service Principle/Secu

Business Wire Receives Type 2 SOC 2 Attestation Engagement Report Related to Security of ‘BW Connect,’ Its Order-Entry Interface, and ‘HQ,’ Its Web-Hosting Services19.10.2017 22:03Tiedote

Business Wire today announced that it has successfully completed a Type 2 SOC 2 examination of its BW Connect and HQ systems. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006400/en/ The attestation engagement report, conducted by the independent CPA firm Schellman & Company, LLC, confirms that Business Wire has met the standards established by the American Institute of Certified Public Accountants [AICPA] Trust Services Principles related to security. BW Connect is Business Wire’s proprietary web-based order-entry system; HQ provides web-hosting services for online newsrooms, and investor relations hubs for publicly-traded companies. The examination, conducted during the review period February 1, 2017 through July 31, 2017, focused on Business Wire adherence to the Trust Service Principle/Secu

Pharnext: First-Half 201719.10.2017 20:30Tiedote

Regulatory News: Pharnext SA (FR00111911287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositioning of known drugs, today announced its first-half 2017 financial results. Daniel Cohen, M.D., Ph.D. Co-Founder and CEO said of activity for the first half of 2017: "Activity in the first-half of the year was very dense; we implemented two prominent strategic partnerships with the biotech company Galapagos and the Tasly Group, one of the top ten pharmaceutical companies in China. Our flagship product, PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A, is nearing the end of Phase 3, which is slated for the second half of 2018. We confirm our target of taking the product to market by 2019." A half-year marked by strategic agreements

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme